Cargando…

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin

The Hippo-YAP pathway is a central regulator of cell contact inhibition, proliferation and death. There are conflicting reports regarding the role of Angiomotin (Amot) in regulating this pathway. While some studies suggest a YAP-inhibitory function other studies indicate Amot is required for YAP act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moleirinho, Susana, Hoxha, Sany, Mandati, Vinay, Curtale, Graziella, Troutman, Scott, Ehmer, Ursula, Kissil, Joseph L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415356/ https://www.ncbi.nlm.nih.gov/pubmed/28464980 http://dx.doi.org/10.7554/eLife.23966

Ejemplares similares

Transcriptional regulation of miR-30a by YAP impacts PTPN13 and KLF9 levels and Schwann cell proliferation
por: Shepard, Alyssa, et al.
Publicado: (2021)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Angiomotin Regulates YAP Localization during Neural Differentiation of Human Pluripotent Stem Cells
por: Zaltsman, Yefim, et al.
Publicado: (2019)

Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1
por: Troutman, Scott, et al.
Publicado: (2016)

Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP
por: Lv, Meng, et al.
Publicado: (2016)

Angiomotin links ROCK and YAP signaling in mechanosensitive differentiation of neural stem cells
por: Kang, Phillip H., et al.
Publicado: (2020)

YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation
por: He, Lizhi, et al.
Publicado: (2021)

Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
por: Zeng, Hao, et al.
Publicado: (2016)

Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2
por: Doherty, Joanne, et al.
Publicado: (2022)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
por: Jiang, Wen G, et al.
Publicado: (2006)

YAP1 Recruits c-Abl to Protect Angiomotin-Like 1 from Nedd4-Mediated Degradation
por: Skouloudaki, Kassiani, et al.
Publicado: (2012)

Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling
por: Xie, Wenlin, et al.
Publicado: (2020)

Targeting YAP‐p62 signaling axis suppresses the EGFR‐TKI‐resistant lung adenocarcinoma
por: Park, Hee Sun, et al.
Publicado: (2021)

Angiomotin functions in HIV-1 assembly and budding
por: Mercenne, Gaelle, et al.
Publicado: (2015)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
por: Chai, Yuhang, et al.
Publicado: (2019)

YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia
por: Hatterschide, Joshua, et al.
Publicado: (2022)

Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis
por: Nokin, Marie-Julie, et al.
Publicado: (2016)

YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways
por: Song, Yongchun, et al.
Publicado: (2019)

Helicobacter pylori‐induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL‐1β expression
por: Wu, Yujiao, et al.
Publicado: (2019)

Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma
por: Avila, Jacqueline L., et al.
Publicado: (2012)

Hold That Line: Angiomotin Regulates Endothelial Cell Motility
por: Zetter, Bruce R.
Publicado: (2001)

Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2
por: Chinthalapudi, Krishna, et al.
Publicado: (2018)

Angiomotin mutation causes glomerulopathy and renal cysts by upregulating hepatocyte nuclear factor transcriptional activity
por: Zhang, Yaochun, et al.
Publicado: (2022)

Long noncoding RNA HCG18 up‐regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR‐141‐3p in gastric cancer
por: Liu, Yan, et al.
Publicado: (2020)

Angiomotins link F-actin architecture to Hippo pathway signaling
por: Mana-Capelli, Sebastian, et al.
Publicado: (2014)

Early prediction of revascularisation by angiomotin-targeting positron emission tomography
por: Moyon, Anais, et al.
Publicado: (2018)

Identification of Specific Lysines and Arginines That Mediate Angiomotin Membrane Association
por: Hall, Le’Celia, et al.
Publicado: (2019)

MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages
por: Curtale, Graziella
Publicado: (2018)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development
por: Hirate, Yoshikazu, et al.
Publicado: (2014)

Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
por: Li, Youjun, et al.
Publicado: (2015)

The polarity protein Angiomotin p130 controls dendritic spine maturation
por: Wigerius, Michael, et al.
Publicado: (2018)

Dissecting transcriptional amplification by MYC
por: Nie, Zuqin, et al.
Publicado: (2020)

Hippo Signaling in the Liver – A Long and Ever-Expanding Story
por: Manmadhan, Saumya, et al.
Publicado: (2019)

Pivotal role of the transcriptional co-activator YAP in trophoblast stemness of the developing human placenta
por: Meinhardt, Gudrun, et al.
Publicado: (2020)

Angiomotin: An Angiostatin Binding Protein That Regulates Endothelial Cell Migration and Tube Formation
por: Troyanovsky, Boris, et al.
Publicado: (2001)

Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
por: Paramasivam, Murugan, et al.
Publicado: (2011)

Dynamic Nature of Noncoding RNA Regulation of Adaptive Immune Response
por: Curtale, Graziella, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0hmng71kfo6lndutvialebgd64